Upper Gastrointestinal Manifestations in Rheumatoid Arthritis Patients: Intrinsic or Extrinsic Pathogenesis?

References

• Lindsay M K, Tavadia H B, Whyte A S, et al. Arteritis and infarction of the intestine in rheumatoid arthritis. Br Med J 1973; 2: 592–593
   PubMed Web of Science ®Google Scholar
• Adler R H, Norcross B M, Lockie M. Arteritis and infarction of the intestine in rheumatoid arthritis. JAMA 1962; 180: 921–926
   PubMed Web of Science ®Google Scholar
• Sun D CH, Roth S H, Mitchell C S, England DW. Upper gastrointestinal disease in rheumatoid arthritis. Dig Dis 1974; 19: 405–410
   Web of Science ®Google Scholar
• Committee on the Safety of Medicines. CSM update: non-steroidal anti-inflammatory drugs and serious gastrointestinal adverse reactions. Br Med J 1986; 1: 1190–1191
   Google Scholar
• Paulus HE. FDA arthritis advisory committee meeting: postmarketing surveillance of nonsteroidal anti-inflammatory drugs. Arthritis Rheum 1985; 281: 1168–1169
   Google Scholar
• Silvoso G R, Ivey J J, Butt J H, et al. Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy. Ann Intern Med 1979; 91: 517–520
   PubMed Web of Science ®Google Scholar
• Armstrong C P, Blower AL. Non-steroidal antiinflammatory drug and life-threatening complications of peptic ulceration. Gut 1987; 28: 527–532
   PubMed Web of Science ®Google Scholar
• Collier D S, Pain JA. Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut 1985; 26: 259–263
   Web of Science ®Google Scholar
• Jick S S, Perera D R, Walter A M, Jick H. Nonsteroidal anti-inflammatory drugs and hospital admission for perforated peptic ulcer. Lancet 1987; 2: 380–382
   PubMed Web of Science ®Google Scholar
• Walt R, Katschinski B, Logan R, Ashly, Langman M. Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet 1986; 1: 489–492
   PubMed Web of Science ®Google Scholar
• Dooley C P, Cohen H. The clinical significance of Campylobacter pylori. Ann Intern Med 1988; 108: 70–79
   PubMed Web of Science ®Google Scholar
• Upadhyay R, Howatson A, McKinlcy A, Danesh B JZ, Sturrock R D, Rusell RI. Campylobacter pylori associated gastritis in patients with rheumatoid arthritis taking nonsteroidal anti-inflammatory drugs. Br J Rheumatol 1988; 27: 113–116
   PubMedGoogle Scholar
• Iglehart I W, Edlow D W, Mills L, Morrison S A, Hodberg MC. The presence of Campylobacter pylori in nonsteroidal antiinflammatory drug associated gastritis. J Rheumatol 1989; 16: 599–603
   PubMed Web of Science ®Google Scholar
• Braga L L, Sarosick Marshall B, McCallum R W, Barrett L, Guerrant R. Gold–a new potential drug for the treatment of helicobacter pylori infection [Abstract]. Gastroenterology 1990; 98: A25
   PubMed Web of Science ®Google Scholar
• Walsh J H, Grossmann MI. Gastrin. N Engl J Med 1975; 292: 1324–1334; 1377–1383
   PubMed Web of Science ®Google Scholar
• Rooney P J, Dick W C, Imrie R C, Buchanan KD. An animal model for the study of the relationship between immunoreactive gastrin and inflammatory arthritis. Nature 1973; 246: 497–498
   PubMed Web of Science ®Google Scholar
• Rooney P J, Vince J, Kennedy A C, et al. Hyper-gastrinaemia in rheumatoid arthritis: disease or iatrogenesis. Br Med J 1973; 2: 752–753
   PubMed Web of Science ®Google Scholar
• De Witte T J, Geerdink P J, Lamers CB, Boerbooms A M, van der Korst JK. Hypochlorhydria and hypergastrinaemia in rheumatoid arthritis. Ann Rheum Dis 1979; 38: 14–17
   PubMed Web of Science ®Google Scholar
• Yorke A J, Davies P, Salkie M, Weinstein W, Thomson A BR. Hypergastrinaemia in rheumatoid arthritis. Clin Exp Rheum 1986; 4: 49–52
   PubMed Web of Science ®Google Scholar
• Rowden D R, Taylor I L, Richter J A, Pinals R S, Levine RA. Is hypergastrinaemia associated with rheumatoid arthritis?. Gut 1978; 19: 1064–1067
   PubMed Web of Science ®Google Scholar
• Taglieri G, Piga M, Ibba G, Piras M R, Uras R. Gastrine serique au cours de la polyarthritis rheumatoide. Rev Rhum Mai Osteoartic 1982; 49: 533–535
   PubMedGoogle Scholar
• Bins M. Relations between gastric acid, serum gastrin, parietal cell antibodies and the HLA system [Thesis]. University of Groningen, Groningen 1981
   Google Scholar
• Rooney P J, Grennan D M, Sturrock R D, Brooks P M, Dick WC. Serum immunoreactive gastrin: specificity for rheumatoid arthritis, bimodality of distribution, and failure of effect of anti-inflammatory drugs. Ann Rheum Dis 1976; 35: 40–45
   PubMed Web of Science ®Google Scholar
• Rooney P J, Kennedy A C, Gray G H, Sturrock R D, Buchanan K D, Dick WC. Serum immunoreactive gastrin in rheumatoid arthritis. Ann Rheum Dis 1976; 35: 246–250
   PubMed Web of Science ®Google Scholar
• Feldman M, Colturi TJ. Effect of indomethacin on gastric and bicarbonate secretions in humans. Gastroenterology 1984; 87: 1339–1343
   PubMed Web of Science ®Google Scholar
• Curtarelli G, Caldara R, Bierti L. Effect of antiinflammatory agents on serum gastrin concentration. Ann Rheum Dis 1977; 36: 97
   PubMed Web of Science ®Google Scholar
• Lanzon-Miller S, Allison M C, Pounder R E, Ball S, Hamilton M R, Chronos N AF. Enprostil inhibits postprandial gastrin release: a dose-response study. Aliment Pharmacol Therap 1988; 2: 317–323
   PubMed Web of Science ®Google Scholar
• Strickland R G, Mackay IR. A reappraisal of the nature and significance of chronic atrophic gastritis. Dig Dis 1973; 18: 426–440
   Web of Science ®Google Scholar
• Roitt IM. Essential immunology.6th ed. Blackwell Scientific Publications, Oxford 1988
   Google Scholar
• Partridge R E, Duthie JJ. Incidence of macrocytic anaemia in rheumatoid arthritis. Br Med J 1963; 1: 89–91
   PubMed Web of Science ®Google Scholar
• Ghazi HA. Pernicious anaemia in rheumatoid arthritis. Br Med J 1972; 1: 144–145
   PubMed Web of Science ®Google Scholar
• Bieder L, Wigley RD. Vit B12 deficiency in rheumatoid arthritis. A study of haemotological and neuropsychiatry changes. NZ Med J 1964; 63: 375–378
   PubMedGoogle Scholar
• Schneedorf J C, Bradley W B, Ivy AC. Effect of prolonged administration of salicylate upon gastric activity and the modifying action of calcium gluconate and sodium bicarbonate. Am J Dig Dis Nutr 1936; 3: 239
   Google Scholar
• Robert A. Prostaglandins and the gastrointestinal tract. Physiology of the gastrointestinal tract, LR Jonson. Raven Press, New York 1981; 1407–1434
   Google Scholar
• Feldman M. Gastric bicarbonate secretion in humans. Effect of pentagastrin, bethanechol, and 11,16,16-trimethyl prostaglandin E-. J Clin Invest 1983; 72: 295–303
   PubMed Web of Science ®Google Scholar
• Lunghetti R, Bianco G, Marcolongo R, Carcassi A. Effect of indomethacin on gastric function. Settim Med 1967; 55: 1339–1353
   Google Scholar
• Marcolongo R. Undesirable side effects of indomethacin. Clin Ter 1972; 60: 343–353
   PubMedGoogle Scholar
• Samloff I M, Secrist D M, Passano E, Jr. A study of the relationship between serum group I Pepsinogen levels and gastric acid secretion. Gastroenterology 1975; 69: 1196–1200
   PubMed Web of Science ®Google Scholar
• Samloff I M, Liebman W M, Panitch HM. Serum group I pepsinogens by radioimmunoassay in control subjects and patients with peptic ulcer. Gastroenterology 1975; 69: 83–90
   PubMed Web of Science ®Google Scholar
• Varis K, Samloff I M, Ihamaki T, Siurala M. An appraisal of tests for severe atrophic gastritis in relatives of patients with pernicious anaemia. Dig Dis Sci 1979; 24: 187–191
   PubMed Web of Science ®Google Scholar
• Maury C PJ, Rasanen V, Teppo A M, Helve T, Wegelius O. Serum pepsinogen I in rheumatic diseases. Arthritis Rheum 1982; 25: 9, 1059–1063
   Google Scholar
• Hengels K J, Peters J. Gastric side effects of nonsteroidal anti-inflammatory drugs: early detection by radioimmunoassay of serum pepsinogens [Abstract]. Gastroenterology 1985; 92: 1432
   Web of Science ®Google Scholar
• Hengels KJ., Zeidler H, Samloff JM. Asymptomatic gastric side effects of nonsteroidal anti-inflammatory drugs: detection by radioimmunoassay of serum pepsinogens [Abstract]. Gastroenterology 1985; 92: 1417
   Google Scholar
• Marshall B J, McGechie D B, Rogers P A, Glancy RJ. Pyloric Campylobacter infections and gastro-duodenal disease. Med J Aust 1985; 142: 439–444
   PubMed Web of Science ®Google Scholar
• Caselli M, Pazzi P, Lacorte R, Aleotti A, Trevisani L, Stabellini G. Campylobacter-like organisms, nonsteroidal anti-inflammatory drugs and gastric lesions in patients with rheumatoid arthritis. Digestion 1989; 44: 101–104
   PubMed Web of Science ®Google Scholar
• Keers RY. The gold rush 1925-35. Thorax 1980; 35: 884–889
   PubMed Web of Science ®Google Scholar
• Henry H A, Johnston A, Dobson A, Duggan J. Fatal peptic ulcer complications and the use of non steroidal anti-inflammatory drugs, aspirin and corticosteroids. Br Med J 1987; 2: 1227–1229
   Google Scholar
• Langman M JS. Ulcer complications and nonsteroidal anti-inflammatory drugs. Am J Med 1988; 84: 15–19
   PubMed Web of Science ®Google Scholar
• Malone D E, McCormick P A, Daly L, et al. Peptic ulcer in rheumatoid arthritis–intrinsic or related to drug therapy. Br J Rheum 1986; 25: 342–344
   PubMedGoogle Scholar
• Somerville K, Faulkner G, Langman M. Nonsteroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986; 1: 462–464
   PubMed Web of Science ®Google Scholar